Xylitol and Heart Risk: What Dentists Need to Know
For decades, xylitol has enjoyed a favorable reputation in dentistry. It is noncariogenic, widely used in sugar free gum and oral care products, and often presented as a smarter alternative to sucrose. New cardiovascular research does not overturn that history, but it does challenge a comfortable assumption, that a sweetener that is good for teeth must also be harmless everywhere else in the body.
The latest concern comes from a 2026 analysis of 17,710 participants in the Canadian Longitudinal Study on Aging and the EPIC Norfolk cohort in the United Kingdom. Researchers measured circulating xylitol and followed participants for major cardiovascular events, including death, myocardial infarction, and stroke. In the Canadian cohort, people with the highest blood xylitol concentrations had a 57 percent higher adjusted risk of a major cardiovascular event over six years compared with those in the lowest quarter. In the longer EPIC Norfolk follow up, the highest group had an 18 percent greater risk. Cardiovascular risk generally increased as circulating xylitol rose.
Those numbers are easy to sensationalize. The study measured xylitol in blood. It did not measure how many pieces of gum people chewed or how much dietary xylitol they consumed. Humans naturally produce xylitol as part of normal metabolism, so high fasting concentrations may reflect dietary exposure, underlying metabolism, or both. The 2026 findings were also presented at the European Society of Cardiology Congress and have not yet undergone full peer reviewed publication.
The signal becomes more interesting because it is not isolated. A 2024 European Heart Journal study involving more than 3,000 patients undergoing cardiac evaluation also found that people with the highest circulating xylitol levels had a 57 percent higher adjusted risk of major cardiovascular events. Researchers then moved beyond observation. In laboratory studies, xylitol increased platelet responsiveness. In mice, it accelerated thrombus formation. In a small human experiment, 10 healthy volunteers consumed 30 grams of xylitol in water. Their blood xylitol concentrations rose dramatically, and platelet responsiveness increased.
That still does not mean xylitol gum causes heart attacks. The human experiment involved a large dose, far more than most patients would consume from a few pieces of gum, and researchers measured platelet behavior rather than actual cardiovascular events. But the combination of epidemiology, platelet biology, animal data, and human exposure means the safety question deserves attention.
Dentistry also needs to examine the other side of the equation. How strong is the benefit we are trying to preserve? The American Dental Association has long taken a more cautious position than many product claims suggest. Xylitol is noncariogenic and may have cariostatic effects, but the ADA has described the evidence for a unique xylitol benefit as equivocal. Replacing fermentable sugar with a noncariogenic sweetener is clearly useful. Proving that xylitol itself provides a large additional therapeutic effect is harder.
Recent systematic reviews reinforce that uncertainty. One 2024 review of pediatric studies found that xylitol chewing gum reduced caries most consistently in children who already had moderate or high caries experience. The strongest results generally involved several grams of xylitol daily, divided into multiple exposures. Yet none of the included studies was rated high quality, study designs varied widely, and manufacturer involvement was common. Xylitol candies and lozenges performed much less consistently.
Another 2024 systematic review concluded that the anticaries effect of xylitol could not be determined with certainty. The largest adult trial, involving 691 high risk adults taking 5 grams of xylitol daily for 33 months, found an 11 percent reduction in caries increment that was not statistically significant. Many smaller studies measured reductions in Streptococcus mutans rather than actual new cavities. Lowering one bacterial species is not the same as proving fewer restorations or less disease.
Chewing gum itself also complicates the story. Gum stimulates saliva, improves buffering, promotes clearance, and supports remineralization. If a xylitol gum group is compared with a no gum group, some of the benefit may come from chewing rather than from xylitol.
For practicing dentists, this should change the conversation more than the treatment plan. There is currently no evidence that normal use of xylitol toothpaste increases cardiovascular risk, and there is not enough evidence to tell patients that ordinary xylitol gum consumption causes heart attacks or strokes. The sensible response is not to replace xylitol with sugar. It is to stop presenting xylitol as unquestionably beneficial or systemically inert.
A high caries risk patient may still reasonably use xylitol gum as one adjunct among fluoride, dietary counseling, salivary stimulation, and appropriate recall. But recommending several grams of xylitol every day to a low risk patient simply because xylitol carries a health halo is becoming harder to justify.
If a patient asks whether xylitol is dangerous, the best answer today is simple. High blood xylitol levels have been associated with cardiovascular events, and large doses can increase platelet responsiveness, but researchers have not shown that ordinary xylitol gum or toothpaste causes heart attacks or strokes.
For now, xylitol remains a useful noncariogenic sugar substitute and may offer additional benefit in selected high risk patients. But it no longer deserves an unquestioned health halo.
If the dental benefit is modest and the systemic risk remains uncertain, how much xylitol should we really be recommending?
Join the Conversation!